Vector Competence of Aedes albopictus Populations from the Northeastern United States for Chikungunya, Dengue, and Zika Viruses.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
21 12 2020
Historique:
received: 17 07 2020
accepted: 10 11 2020
pubmed: 24 12 2020
medline: 10 2 2022
entrez: 23 12 2020
Statut: epublish

Résumé

The Asian tiger mosquito (Aedes albopictus) is an important vector of a number of arboviruses, including Zika (ZIKV), dengue (DENV), and chikungunya (CHIKV) viruses, and has recently expanded its range in the eastern United States to southern New England and New York. Given the recent establishment and proliferation of Ae. albopictus in this region and the increasing amount of international travel between the United States and endemic countries, there is a need to elucidate the public health risk posed by this mosquito species in the Northeast. Accordingly, we evaluated the competence of four Ae. albopictus populations from Connecticut and New York, for two strains each of ZIKV, DENV serotype 2 (DENV-2), and CHIKV, currently circulating in the Americas, to evaluate the local transmission risk by this vector. We found that local Ae. albopictus populations are susceptible to infection by all three viruses but are most capable of transmitting CHIKV. Variation in competence was observed for ZIKV and CHIKV, driven by the virus strains and mosquito population, whereas competence was more homogeneous for the DENV-2 strains under evaluation. These results suggest that under optimal circumstances, Ae. albopictus could support localized transmission of these viruses and emphasize the importance of maintaining mosquito surveillance and control programs to suppress Ae. albopictus populations and limit further range expansion of this species.

Identifiants

pubmed: 33355070
pii: tpmd200874
doi: 10.4269/ajtmh.20-0874
pmc: PMC7941830
doi:
pii:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1123-1130

Subventions

Organisme : NCEZID CDC HHS
ID : U01 CK000509
Pays : United States

Auteurs

Andrea Gloria-Soria (A)

1Department of Environmental Sciences, Center for Vector Biology and Zoonotic Diseases, The Connecticut Agricultural Experiment Station, New Haven, Connecticut.

Anne F Payne (AF)

2The Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, Slingerlands, New York.

Sean M Bialosuknia (SM)

2The Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, Slingerlands, New York.

Jessica Stout (J)

2The Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, Slingerlands, New York.

Nicholas Mathias (N)

2The Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, Slingerlands, New York.

Gillian Eastwood (G)

1Department of Environmental Sciences, Center for Vector Biology and Zoonotic Diseases, The Connecticut Agricultural Experiment Station, New Haven, Connecticut.
3Department of Entomology, Virginia Polytechnic Institute and State University, Blacksburg, Virginia.

Alexander T Ciota (AT)

2The Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, Slingerlands, New York.
4Department of Biomedical Sciences, State University of New York at Albany School of Public Health, Albany, New York.

Laura D Kramer (LD)

2The Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, Slingerlands, New York.
4Department of Biomedical Sciences, State University of New York at Albany School of Public Health, Albany, New York.

Philip M Armstrong (PM)

1Department of Environmental Sciences, Center for Vector Biology and Zoonotic Diseases, The Connecticut Agricultural Experiment Station, New Haven, Connecticut.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH